Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar
PMC(0)


Article History
Submitted: 19 Aug 2015
Revised: 14 Feb 2016
Accepted: 16 Feb 2016
First published online: 17 Mar 2016

Article Access Statistics
Abstract Page Views: 307
PDF Downloads: 171
Full Text Views: 0

Adv Pharm Bull. 2016;6(1):91-98 doi: 10.15171/apb.2016.014
PMID:27123423        PMCID:PMC4845540

Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus

Original Research

Khadijeh Nasiri 1, Mohammadreza Nassiri 1,2 * , Mojtaba Tahmoorespour 1, Alireza Haghparast 3, Saeed Zibaee 4

1 Department of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Iran.
2 Institute of Biotechnology, Ferdowsi University of Mashhad, Iran.
3 Department of Veterinary Medicine, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Iran.
4 Razi Vaccine and Serum Research Institute, Mashhad, Iran.



Abstract
Purpose: Bovine Rotavirus and Bovine Coronavirus are the most important causes of diarrhea in newborn calves and in some other species such as pigs and sheep. Rotavirus VP8 subunit is the major determinant of the viral infectivity and neutralization. Spike glycoprotein of coronavirus is responsible for induction of neutralizing antibody response. Methods: In the present study, several prediction programs were used to predict B and T-cells epitopes, secondary and tertiary structures, antigenicity ability and enzymatic degradation sites. Finally, a chimeric antigen was designed using computational techniques. The chimeric VP8-S2 antigen was constructed. It was cloned and sub-cloned into pGH and pET32a(+) expression vector. The recombinant pET32a(+)-VP8-S2 vector was transferred into E.oli BL21CodonPlus (DE3) as expression host. The recombinant VP8-S2 protein was purified by Ni-NTA chromatography column. Results: The results of colony PCR, enzyme digestion and sequencing showed that the VP8-S2 chimeric antigen has been successfully cloned and sub-cloned into pGH and pET32a(+).The results showed that E.coli was able to express VP8-S2 protein appropriately. This protein was expressed by induction of IPTG at concentration of 1mM and it was confirmed by Ni–NTA column, dot-blotting analysis and SDS-PAGE electrophoresis. Conclusion: The results of this study showed that E.coli can be used as an appropriate host to produce the recombinant VP8-S2 protein. This recombinant protein may be suitable to investigate to produce immunoglobulin, recombinant vaccine and diagnostic kit in future studies after it passes biological activity tests in vivo in animal model and or other suitable procedure.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Nasiri K
Articles by Nassiri M
Articles by Tahmoorespour M
Articles by Haghparast A
Articles by Zibaee S

PubMed
Articles by Nasiri K
Articles by Nassiri M
Articles by Tahmoorespour M
Articles by Haghparast A
Articles by Zibaee S

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN